The cytokine production of peripheral blood mononuclear cells reflects the autoantibody profile of patients suffering from type 1 diabetes

Cytokine

Volumn 69, Issue 2, 2014, Pages 189-195

  Labikova, Jana ^a   Vcelakova, Jana ^a   Ulmannova, Tereza ^a   Petruzelkova, Lenka ^a   Kolouskova, Stanislava ^a   Stechova, Katerina ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Autoantibodies; GAD65; IA2; IL17; Type 1 diabetes

Indexed keywords

AUTOANTIBODY; CELL ANTIGEN; CYTOKINE; GAMMA INTERFERON; GLUTAMATE DECARBOXYLASE 65; INSULINOMA ANTIGEN 2; INTERLEUKIN 17; UNCLASSIFIED DRUG; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 2;

ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN DETECTION; ARTICLE; B LYMPHOCYTE; CELL ASSAY; CELL LEVEL; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE SUBPOPULATION; MALE; MOLECULAR DYNAMICS; MONOCYTE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; REGULATORY T LYMPHOCYTE; SCHOOL CHILD; BIOSYNTHESIS; BLOOD; HELPER CELL; IMMUNOLOGY; METABOLISM; MONONUCLEAR CELL; PRESCHOOL CHILD;

AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; FLOW CYTOMETRY; GLUTAMATE DECARBOXYLASE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; LEUKOCYTES, MONONUCLEAR; MALE; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY;

EID: 84903644085     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2014.06.013     Document Type: Article

References (26)

1. Coppieters KT, von Herrath MG. Histopathology of type 1 diabetes: old paradigms and new insights. Rev Diabet Stud [Internet]. 2009;6(2): 85-96. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779010/.
2. Eisenbarth GS. Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 1986;314(21):1360-8.
3. Rabinovitch A., Suarez-Pinzon W.L. Roles of cytokines in the pathogenesis and therapy of type 1 diabetes. Cell Biochem Biophys 2007, 48(2-3):159-163.
4. Miossec P., Korn T., Kuchroo V.K. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009, 361(9):888-898.
5. Bending D., De La Peña H., Veldhoen M., Phillips J.M., Uyttenhove C., Stockinger B., et al. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J Clin Invest 2009, 119(3):565-572.
6. Roep B.O., Peakman M. Antigen targets of type 1 diabetes autoimmunity. Cold Spring Harb Perspect Med 2012, 2(4):a007781.
7. Tian J., Atkinson M.A., Clare-Salzler M., Herschenfeld A., Forsthuber T., Lehmann P.V., et al. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med 1996, 183(4):1561-1567.
8. Muir A., Peck A., Clare-Salzler M., Song Y.H., Cornelius J., Luchetta R., et al. Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription. J Clin Invest 1995, 95(2):628-634.
9. Tisch R., Liblau R.S., Yang X.D., Liblau P., McDevitt H.O. Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice. Diabetes 1998, 47(6):894-899.
10. Skyler J.S., Krischer J.P., Wolfsdorf J., Cowie C., Palmer J.P., Greenbaum C., et al. Effects of oral insulin in relatives of patients with type 1 diabetes: the diabetes prevention trial-type 1. Diabetes Care 2005, 28(5):1068-1076.
11. Schloot NC, Meierhoff G, Karlsson Faresjö M, Ott P, Putnam A, Lehmann P, et al. Comparison of cytokine ELISpot assay formats for the detection of islet antigen autoreactive T cells. Report of the third immunology of diabetes society T-cell workshop. J Autoimmun 2003;21(4):365-76.
12. Peakman M., Tree T.I., Endl J., van Endert P., Atkinson M.A., Roep B.O., et al. Characterization of preparations of GAD65, proinsulin, and the islet tyrosine phosphatase IA-2 for use in detection of autoreactive T-cells in type 1 diabetes: report of phase II of the Second International Immunology of Diabetes Society Workshop for Standardization of T-cell assays in type 1 diabetes. Diabetes 2001, 50(8):1749-1754.
13. Stechova K., Bohmova K., Vrabelova Z., Sepa A., Stadlerova G., Zacharovova K., et al. High T-helper-1 cytokines but low T-helper-3 cytokines, inflammatory cytokines and chemokines in children with high risk of developing type 1 diabetes. Diabetes Metab Res Rev 2007, 23(6):462-471.
14. Vrabelova Z., Hrotekova Z., Hladikova Z., Bohmova K., Stechova K., Michalek J. CD 127- and FoxP3+ expression on CD25+CD4+ T regulatory cells upon specific diabetogeneic stimulation in high-risk relatives of type 1 diabetes mellitus patients. Scand J Immunol 2008 Apr, 67(4):404-410.
15. Monti P, Scirpoli M, Rigamonti A, Mayr A, Jaeger A, Bonfanti R, et al. Evidence for in vivo primed and expanded autoreactive T cells as a specific feature of patients with type 1 diabetes. J Immunol Baltim Md 2007;179(9):5785-92.
16. Ludvigsson J., Krisky D., Casas R., Battelino T., Castaño L., Greening J., et al. GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus. N Engl J Med 2012, 366(5):433-442.
17. Vukkadapu S.S., Belli J.M., Ishii K., Jegga A.G., Hutton J.J., Aronow B.J., et al. Dynamic interaction between T cell-mediated beta-cell damage and beta-cell repair in the run up to autoimmune diabetes of the NOD mouse. Physiol Genomics 2005, 21(2):201-211.
18. Emamaullee J.A., Davis J., Merani S., Toso C., Elliott J.F., Thiesen A., et al. Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes 2009 Jun, 58(6):1302-1311.
19. Ferraro A., Socci C., Stabilini A., Valle A., Monti P., Piemonti L., et al. Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes. Diabetes 2011, 60(11):2903-2913.
20. Pietropaolo M., Towns R., Eisenbarth G.S. Humoral autoimmunity in type 1 diabetes: prediction, significance, and detection of distinct disease subtypes. Cold Spring Harb Perspect Med 2012, 2(10):a012831.
21. Coppieters K.T., Dotta F., Amirian N., Campbell P.D., Kay T.W.H., Atkinson M.A., et al. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J Exp Med 2012, 209(1):51-60.
22. Graham J., Hagopian W.A., Kockum I., Li L.S., Sanjeevi C.B., Lowe R.M., et al. Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes 2002 May, 51(5):1346-1355.
23. Kukreja A., Cost G., Marker J., Zhang C., Sun Z., Lin-Su K., et al. Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest 2002 Jan, 109(1):131-140.
24. Putnam A.L., Vendrame F., Dotta F., Gottlieb P.A. CD4+CD25high regulatory T cells in human autoimmune diabetes. J Autoimmun 2005, 24(1):55-62.
25. Lindley S., Dayan C.M., Bishop A., Roep B.O., Peakman M., Tree T.I.M. Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes 2005, 54(1):92-99.
26. Brusko T.M., Wasserfall C.H., Clare-Salzler M.J., Schatz D.A., Atkinson M.A. Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes. Diabetes 2005, 54(5):1407-1414.